Opentrons, Pandemic Response Lab
Biotechnology, 131 Innovation Dr, Long Island City, New York, 92617, United States, 501-1000 Employees
Phone Number: 34********
Who is OPENTRONS, PANDEMIC RESPONSE LAB
As we enter the third year of the COVID-19 pandemic, we recognize that although the pandemic isnt over, it has transitioned into a new phase. In light of a rapidly changing external envir...
Read More
- Headquarters: 131 Innovation Dr, Long Island City, New York, 92617, United States
- Date Founded: 2020
- Employees: 501-1000
- Revenue: $25 Million to $50 Million
- Active Tech Stack: See technologies
Industry: Biotechnology
Does something look wrong? Fix it. | View contact records from OPENTRONS, PANDEMIC RESPONSE LAB
Opentrons, Pandemic Response Lab Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Opentrons, Pandemic Response Lab
Answer: Opentrons, Pandemic Response Lab's headquarters are located at 131 Innovation Dr, Long Island City, New York, 92617, United States
Answer: Opentrons, Pandemic Response Lab's phone number is 34********
Answer: Opentrons, Pandemic Response Lab's official website is https://pandemicresponselab.com
Answer: Opentrons, Pandemic Response Lab's revenue is $25 Million to $50 Million
Answer: Opentrons, Pandemic Response Lab has 501-1000 employees
Answer: Opentrons, Pandemic Response Lab is in Biotechnology
Answer: Opentrons, Pandemic Response Lab contact info: Phone number: 34******** Website: https://pandemicresponselab.com
Answer: As we enter the third year of the COVID-19 pandemic, we recognize that although the pandemic isnt over, it has transitioned into a new phase. In light of a rapidly changing external environment, we have made the difficult decision to wind down operations for PRL effective 12/31/22 and make a strategic pivot to center our lab services on non-clinical lab customers. This shift points our company to areas where we can make the most significant impact in the most differentiated way. We will no longer be accepting samples after 12/27 and will reassign our sequencing core and biosurveillance activities to our sister company Neochromosomes biofoundry operations. We are grateful to everyone who contributed to making PRL an invaluable public health resource and a successful business during the COVID-19 pandemic. Thank you for the opportunity to serve. The PRL Team
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month